Positive contrast magnetic resonance imaging of cells labeled with magnetic nanoparticles

Magnetic Resonance in Medicine

Volumn 53, Issue 5, 2005, Pages 999-1005

  Cunningham, Charles H ^a,c   Arai, Takayasu ^b   Yang, Phillip C ^b   McConnell, Michael V ^b   Pauly, John M ^a   Conolly, Steven M ^a  

^a Stanford University   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NONE   (United States)

Author keywords

Ferumoxides; Nanoparticle; Paramagnetic contrast agent; Selective excitation; SPIO

Indexed keywords

CELLS; CYTOLOGY; IRON OXIDES; MAGNETIC RESONANCE IMAGING; MAGNETISM; MOLECULES; NANOPARTICLES;

FERUMOXIDES; IN-VIVO EXPERIMENTS; MAGNETIC FIELD INHOMOGENEITIES; PARAMAGNETIC CONTRASTS; PARTIAL VOLUME EFFECT; SELECTIVE EXCITATIONS; SPIO; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLES;

MAGNETIC NANOPARTICLES;

CONTRAST MEDIUM; NANOPARTICLE; SUPERPARAMAGNETIC IRON OXIDE; WATER;

ANIMAL CELL; ARTICLE; CELL LABELING; CONTRAST ENHANCEMENT; MOUSE; NANOTECHNOLOGY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PHANTOM;

EID: 18244402192     PISSN: 07403194     EISSN: None     Source Type: Journal    
DOI: 10.1002/mrm.20477     Document Type: Article

References (23)

1. Dias MHM, Lauterbur PC. Ferromagnetic particles as contrast agents for magnetic resonance imaging of liver and spleen. Magn Reson Med 1986;3:328-330.
2. Fahlvik AK, Klaveness J, Stark DD. Iron oxides as MR imaging contrast agents. J Magn Reson Imaging 1993;3:187-1994.
3. Weissleder R, Cheng HC, Bogdanova A, Bogdanov A, Jr. Magnetically labeled cells can be detected by MR imaging. J Magn Reson Imaging 1997;7:258-263.
4. Bowen CV, Zhang X, Saab G, Gareau PJ, Rutt, BK. Application of the static dephasing regime theory to superparamagnetic iron-oxide loaded cells. Magn Reson Med 2002;48:52-61.
5. Foster-Gareau P, Heyn C, Alejski A, Rutt BK. Imaging single mammalian cells with a 1.5 T clinical MRI scanner. Magn Reson Med 2003;49: 968-971.
6. Bulte JWM, Zhang S.-C. van Gelderen P, Herynek V, Jordan EK, Duncan ID, Frank JA. Neurotransplantation of magnetically labeled oligodendrocyte progenitors: magnetic resonance tracking of cell migration and myelination. Proc Natl Acad Sci USA 1999;96:15256-15261.
7. Schmitz SA, Taupitz M, Wagner S, Wolf KJ, Beyersdorff D, Hamm B. Magnetic resonance imaging of atherosclrotic plaques using superparamagnetic iron oxide particles. J Magn Reson Imaging 2001;14:355-361.
8. Ruehm SG, Corot C, Vogt P, Kolb S, Debatin JF. Magnetic resonance imaging of atherosclrotic plaque with ultrasmall superparamagnetic particles of iron oxide in hyperlipidemic rabbits. Circulation 2001;103: 415-422.
9. Kooi ME, Cappendijk VC, Cleutjens KBJM, Kessels AGH, Kitslaar PJEHM, Borgers M, Frederik PM, daemen MJAP, van Engelshoven JMA. Accumulations of ultrasmall superparamagnetic particles of iron oxide in human atherosclerotic plaques can be detected by in vivo magnetic resonance imaging. Circulation 2003;107:2453-2458.
10. Weissleder R, Lee AS, Khaw BA, Shen T, Brady TJ. Antimyosin-labeled monocrystalline iron oxide allows detection of myocardial infarct: MR antibody imaging. Radiology 1992;182:381-385.
11. Weissleder R, Moore A, Mahmood U, Bhorade R, Benveniste H, Chiocca EA, Basilion JP. In vivo magnetic resonance imaging of transgene expression. Nat Med 2000;6:351-354.
12. Moore A, Marecos E, Bogdanov JA, Weissleder R. Tumoral distribution of long-circulating dextran-coated iron oxide nanoparticles in a rodent model. Radiology 2000;214:568-574.
13. Posse S. Direct imaging of magnetic field gradients by group spin-echo selection. Magn Reson Med 1992;25:12-29.
14. Seppenwoolde JH, Viergever MA, Bakker CJ. Passive tracking exploiting local signal conservation: the white marker phenomenon. Magn Reson Med 2003;50:784-790.
15. Coristine AJ, Foster P, Deoni SCL, Heyn C, Rutt BK. Positive contrast labelling of spio loaded cells in cell samples and spinal chord injury. In: Proceedings of the 12th Annual Meeting of Ismem, Kyoto, Japan, 2004. p. 163.
16. Hardy PA, Henkelman RM. Transverse relaxation rate enhancement caused by magnetic particulates. Magn Reson Imaging 1989;7:265-275.
17. Yablonskiy DA, Haacke EM. Theory of NMR signal behavior in magnetically inhomogeneous tissues: the static dephasing regime. Magn Reson Med 1994;32:749-763.
18. Schenck JF. The role of magnetic susceptibility in magnetic resonance imaging: MRI magnetic compatibility of the first and second kinds. Med Phys 1996;23:815-843.
19. Garroway AN, Grannell PK, Mansfield P. Image formation in NMR by a selective irradiative process. J Phys C Solid State Phys 1974;7:L457-L462.
20. Pauly J, Le Roux P, Nishimura D, Macovski A. Parameter relations for the Shinnar-Le Roux selective excitation pulse design algorithm. IEEE Trans Med Imaging 1991;10:53-65.
21. Frank JA, Miller BR, Arbab AS, Zywicke HA, Jordan EK, Lewis BK, Bryant LH, Bulte JWM. Clinically applicable labeling of mammalian and stem cells by combining superparamagnetic iron oxides and transfection agents. Radiology 2003;228:480-487.
22. Arbab AS, Yocum GT, Kalish H, Jordan EK, Anderson SA, Khakoo AY, Read EJ, Frank J. Efficient magnetic cell labeling with protamine sulphate complexed to ferumoxides for cellular MRI. Blood 2004;104: 1217-1223.
23. Meyer CH, Pauly JM, Macovski A, Nishimura DG. Simultaneous spatial and spectral selective excitation. Magn Reson Med 1990;15:287-304.